Literature DB >> 26734964

Ventilation and the Response to Hypercapnia after Morphine in Opioid-naive and Opioid-tolerant Rats.

Michael J Emery1, Chase C Groves, Timothy N Kruse, Chen Shi, Gregory W Terman.   

Abstract

BACKGROUND: Opioid-related deaths are a leading cause of accidental death, with most occurring in patients receiving chronic pain therapy. Respiratory arrest is the usual cause of death, but mechanisms increasing that risk with increased length of treatment remain unclear. Repeated administration produces tolerance to opioid analgesia, prompting increased dosing, but depression of ventilation may not gain tolerance to the same degree. This study addresses differences in the degree to which chronic morphine (1) produces tolerance to ventilatory depression versus analgesia and (2) alters the magnitude and time course of ventilatory depression.
METHODS: Juvenile rats received subcutaneous morphine for 3 days (n = 116) or vehicle control (n = 119) and were then tested on day 4 following one of a range of morphine doses for (a) analgesia by paw withdraw from heat or (b) respiratory parameters by plethysmography-respirometry.
RESULTS: Rats receiving chronic morphine showed significant tolerance to morphine sedation and analgesia (five times increased ED50). When sedation was achieved for all animals in a dose group (lowest effective doses: opioid-tolerant, 15 mg/kg; opioid-naive, 3 mg/kg), the opioid-tolerant showed similar magnitudes of depressed ventilation (-41.4 ± 7.0%, mean ± SD) and hypercapnic response (-80.9 ± 15.7%) as found for morphine-naive (-35.5 ± 16.9% and -67.7 ± 15.1%, respectively). Ventilation recovered due to tidal volume without recovery of respiratory rate or hypercapnic sensitivity and more slowly in morphine-tolerant.
CONCLUSIONS: In rats, gaining tolerance to morphine analgesia does not reduce ventilatory depression effects when sedated and may inhibit recovery of ventilation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26734964     DOI: 10.1097/ALN.0000000000000997

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  17 in total

Review 1.  Opioids and Chronic Pain: Where Is the Balance?

Authors:  Mellar P Davis; Zankhana Mehta
Journal:  Curr Oncol Rep       Date:  2016-12       Impact factor: 5.075

2.  Effect of chronic γ-hydroxybutyrate (GHB) administration on GHB toxicokinetics and GHB-induced respiratory depression.

Authors:  Bridget L Morse; Gurkishan S Chadha; Melanie A Felmlee; Kristin E Follman; Marilyn E Morris
Journal:  Am J Drug Alcohol Abuse       Date:  2017-06-29       Impact factor: 3.829

3.  Simple minimally-invasive automatic antidote delivery device (A2D2) towards closed-loop reversal of opioid overdose.

Authors:  Bahar Dhowan; Jongcheon Lim; Michael D MacLean; Alycia G Berman; Min Ku Kim; Qi Yang; Jacqueline Linnes; Chi Hwan Lee; Craig J Goergen; Hyowon Lee
Journal:  J Control Release       Date:  2019-05-31       Impact factor: 9.776

Review 4.  Respiratory depression and brain hypoxia induced by opioid drugs: Morphine, oxycodone, heroin, and fentanyl.

Authors:  Eugene A Kiyatkin
Journal:  Neuropharmacology       Date:  2019-02-05       Impact factor: 5.250

5.  Desensitization and Tolerance of Mu Opioid Receptors on Pontine Kölliker-Fuse Neurons.

Authors:  Erica S Levitt; John T Williams
Journal:  Mol Pharmacol       Date:  2017-11-02       Impact factor: 4.436

6.  Bilateral carotid sinus nerve transection exacerbates morphine-induced respiratory depression.

Authors:  Santhosh M Baby; Ryan B Gruber; Alex P Young; Peter M MacFarlane; Luc J Teppema; Stephen J Lewis
Journal:  Eur J Pharmacol       Date:  2018-07-19       Impact factor: 4.432

7.  Coadministration of Chemokine Receptor Antagonists with Morphine Potentiates Morphine's Analgesic Effect on Incisional Pain in Rats.

Authors:  Saadet Inan; Toby K Eisenstein; Mia N Watson; Menahem Doura; Joseph J Meissler; Christopher S Tallarida; Xiaohong Chen; Ellen B Geller; Scott M Rawls; Alan Cowan; Martin W Adler
Journal:  J Pharmacol Exp Ther       Date:  2018-09-24       Impact factor: 4.030

8.  Intermittent hypercapnic hypoxia induces respiratory hypersensitivity to fentanyl accompanied by tonic respiratory depression by endogenous opioids.

Authors:  Allison D Brackley; Mary Ann Andrade; Glenn M Toney
Journal:  J Physiol       Date:  2020-06-14       Impact factor: 5.182

Review 9.  Neuronal mechanisms underlying opioid-induced respiratory depression: our current understanding.

Authors:  Jan-Marino Ramirez; Nicholas J Burgraff; Aguan D Wei; Nathan A Baertsch; Adrienn G Varga; Helen A Baghdoyan; Ralph Lydic; Kendall F Morris; Donald C Bolser; Erica S Levitt
Journal:  J Neurophysiol       Date:  2021-04-07       Impact factor: 2.714

10.  The use of hypercapnic conditions to assess opioid-induced respiratory depression in rats.

Authors:  Morgan L Crowley; Luis F Restrepo; Lea R Gamez-Jimenez; Avi Patel; Tobias Braun; Victoria L C Pallares; Nicholas P Ho; Morgan E Reeves; Christopher R McCurdy; Lance R McMahon; Takato Hiranita
Journal:  J Pharmacol Toxicol Methods       Date:  2021-07-07       Impact factor: 2.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.